Evidence map›Paper›PMID 26494286›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture.

Katarzyna Malenczyk, Erik Keimpema, Fabiana Piscitelli, Daniela Calvigioni, Peyman Björklund, Kenneth Mackie, Vincenzo Di Marzo, Tomas G M Hökfelt, Agnieszka Dobrzyn, Tibor Harkany

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Astrocytic GPR55 receptors promote glycolysis.Journal of cannabis research · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Fetal Exposure to Cannabis and Childhood Metabolic Outcomes: The Healthy Start Study.The Journal of clinical endocrinology and metabolism · 2022
    Article
  16. The effects of cannabis and cannabinoids on the endocrine system.Reviews in endocrine & metabolic disorders · 2022
    Review
  17. Review
  18. Metabolic Consequences of Gestational Cannabinoid Exposure.International journal of molecular sciences · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 5 countries.

Katarzyna MalenczykDivision of Molecular Neurobiology, Department of Medical Biochemistry & Biophysics, Karolinska Institutet, SE-17177 Stockholm, Sweden; Nencki Institute of Experimental Biology, 02-093 Warsaw, Poland; Department of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, A-1090 Vienna, Austria;
Erik KeimpemaDivision of Molecular Neurobiology, Department of Medical Biochemistry & Biophysics, Karolinska Institutet, SE-17177 Stockholm, Sweden; Department of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, A-1090 Vienna, Austria;
Fabiana PiscitelliEndocannabinoid Research Group, Institute of Biomolecular Chemistry, National Research Council, I-80078 Pozzuoli, Naples, Italy;
Daniela CalvigioniDivision of Molecular Neurobiology, Department of Medical Biochemistry & Biophysics, Karolinska Institutet, SE-17177 Stockholm, Sweden;
Peyman BjörklundDepartment of Surgical Sciences, Uppsala University, SE-75185 Uppsala, Sweden;
Kenneth MackieDepartment of Psychological and Brain Sciences, Gill Center for Neuroscience, Indiana University, Bloomington, IN 47405;
Vincenzo Di MarzoEndocannabinoid Research Group, Institute of Biomolecular Chemistry, National Research Council, I-80078 Pozzuoli, Naples, Italy;
Tomas G M HökfeltDepartment of Neuroscience, Karolinska Institutet, SE-17177 Stockholm, Sweden tibor.harkany@meduniwien.ac.at tomas.hokfelt@ki.se.
Agnieszka DobrzynNencki Institute of Experimental Biology, 02-093 Warsaw, Poland;
Tibor HarkanyDivision of Molecular Neurobiology, Department of Medical Biochemistry & Biophysics, Karolinska Institutet, SE-17177 Stockholm, Sweden; Department of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, A-1090 Vienna, Austria; tibor.harkany@meduniwien.ac.at tomas.hokfelt@ki.se.
Karolinska Institutet · SEMedical University of Vienna · ATIndiana University Bloomington · USInstytut Biologii Doświadczalnej im. Marcelego Nenckiego · PLNational Academies of Sciences, Engineering, and Medicine · USNational Research Council · ITUppsala University · SE

Funding

Neuronal cannabinoidsR01DA011322 · NIDA · UNIVERSITY OF WASHINGTON · PI MACKIE, KENNETH · 1998 to 2014
$3.4M
The neuronal basis of cannabis-induced developmental deficits in the CNSR01DA023214 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HURD, YASMIN L. · 2008 to 2012
$1.6M
Cannabinoid Modulation of Cell FunctionK05DA021696 · NIDA · TRUSTEES OF INDIANA UNIVERSITY · PI MACKIE, KENNETH · 2007 to 2017
$1.3M
NIDA NIH HHS DA011322NIDA NIH HHS DA021696NIDA NIH HHS DA023214NIDA NIH HHS K05 DA021696NIDA NIH HHS R01 DA011322NIDA NIH HHS R01 DA023214
6 · The paper itself

Abstract

Endocannabinoids are implicated in the control of glucose utilization and energy homeostasis by orchestrating pancreatic hormone release. Moreover, in some cell niches, endocannabinoids regulate cell proliferation, fate determination, and migration. Nevertheless, endocannabinoid contributions to the development of the endocrine pancreas remain unknown. Here, we show that α cells produce the endocannabinoid 2-arachidonoylglycerol (2-AG) in mouse fetuses and human pancreatic islets, which primes the recruitment of β cells by CB1 cannabinoid receptor (CB1R) engagement. Using subtractive pharmacology, we extend these findings to anandamide, a promiscuous endocannabinoid/endovanilloid ligand, which impacts both the determination of islet size by cell proliferation and α/β cell sorting by differential activation of transient receptor potential cation channel subfamily V member 1 (TRPV1) and CB1Rs. Accordingly, genetic disruption of TRPV1 channels increases islet size whereas CB1R knockout augments cellular heterogeneity and favors insulin over glucagon release. Dietary enrichment in ω-3 fatty acids during pregnancy and lactation in mice, which permanently reduces endocannabinoid levels in the offspring, phenocopies CB1R(-/-) islet microstructure and improves coordinated hormone secretion. Overall, our data mechanistically link endocannabinoids to cell proliferation and sorting during pancreatic islet formation, as well as to life-long programming of hormonal determinants of glucose homeostasis.

Indexed as

Analysis of VarianceAnimalsEndocannabinoidsFatty Acids, Omega-3FemaleFetusGlucose Tolerance TestImage Processing, Computer-AssistedIslets of LangerhansMiceMice, Inbred C57BLMicroscopy, ConfocalMorphogenesisPregnancyReceptor, Cannabinoid, CB1TRPV Cation ChannelsEndocannabinoidsFatty Acids, Omega-3Receptor, Cannabinoid, CB1TRPV1 protein, mouseTRPV Cation Channelscell adhesiondiabetesG protein-coupled receptormigrationproliferation

Identifiers

PMID26494286
PMCPMC4653226
OpenAlexW1802289987

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.